Falling cost of next-gen sequencing to drive informatics boom

Frost & Sullivan predicts the falling cost of next-generation sequencing (NGS) will cause the informatics market to triple in value by 2018. The company is tipping the sector to grow to $580 million as researchers try to organize and analyze the rapidly expanding pool of data generated by NGS. Item

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

The $58 million financing round represents biopharma industry's growing interest in genomics data.

Clinerion inks a new deal that adds 60 million U.S. patients to its clinical trial patient recruitment system.